Advocacy Group Criticizes Pfizer's COVID-19 Pill IP Bids
Consumer advocacy group Public Citizen says that it's concerned with dozens of Pfizer's new patent applications for a key component of its at-home oral antiviral COVID-19 treatment, Paxlovid....To view the full article, register now.
Already a subscriber? Click here to view full article